Mini Review - Anesthesiology and Clinical Science Research (2023) Volume 7, Issue 2

Anaesthesia for pulmonary hypertension in pregnant women.

Praveen Kumar^*

Department of Anaesthesia and Intensive Care

*Corresponding Author:

Caren Stein
Department of Anaesthesia and Intensive Care
University of Cincinnati
USA
E-mail:Pravkumar@gmail.com

Received:01-Mar-2023,Manuscript No. AAACSR-23-90588; Editor assigned: 03-Mar-2023, PreQC No. AAACSR-23-90588(PQ); Reviewed:17-Mar-2023, QC No. AAACSR-23-90588; Revised:22-Mar-2023, Manuscript No. AAACSR-23-90588(R); Published:29-Mar-2023, DOI: 10.35841/aaacsr-7.2.136

Citation: Kumar P. Anaesthesia for pulmonary hypertension in pregnant women. Anaesthesiol Clin Sci Res. 2023;7(2):136

Abstract

Anesthesia refers to a medical practice that is used to temporarily eliminate sensations and consciousness in patients. The goal of anesthesia is to make patients comfortable during medical procedures that would otherwise cause pain, anxiety, or discomfort. Anesthesia can also be used to control pain after surgery or manage chronic pain conditions.

Abstract

The prognosis for pregnant women with pulmonary hypertension is still dismal, with a significant maternal mortality rate, despite improvements in treatment over the past few decades. This presents a unique problem for the mother and her medical staff. A "pregnancy heart team" is crucial to enhancing the long-term outcomes of pregnant women with pulmonary hypertension, according to the authors of the present review, who also updated the classification and definition of pulmonary hypertension. They also summarised the most recent knowledge regarding perioperative management and anaesthesia considerations for these patients.

Keywords

Anesthesia, Pulmonary Hypertension, Cardiovascular Diseases (CVD), Hemodynamic.

Introduction

In many developed nations and developed regions of China, heart disease has supplanted postpartum haemorrhage and urinary tract infection as the primary cause of indirect maternal death. 5 In these regions, better heart disease diagnostic and treatment options have increased the number of heart disease-afflicted women who live to reproductive age. Changes in physiology during pregnancy could make an existing cardiac issue worse. As a result, the interaction between pregnancy and CVD leads to pathophysiologic alterations in pregnant women with CVD.[1].

This essentially suggests that the disorders (CVD or pregnancy) shouldn't be treated separately. Changes in physiology during pregnancy could make an existing cardiac issue worse. As a result, the interaction between pregnancy and CVD leads to pathophysiologic alterations in pregnant women with CVD. This essentially suggests that the disorders (CVD or pregnancy) shouldn't be treated separately.[2].

Cardiac Output (CO) starts to rise during the fifth week of pregnancy and by the end of the first trimester; it has risen by 35% to 40% above baseline. Individuals with PH frequently experience vague symptoms in the first trimester, including as fatigue and dyspnea with exertion, which can prevent PH and other CVDs from being correctly diagnosed. Throughout the second trimester, the concentration of CO steadily rises; as a result, the Systemic and pulmonary Vascular Resistances (SVR).[3].

Anesthesiologists must take several specific precautions in addition to the fundamental anaesthetic guidelines while managing critically ill patients. One of the critical factors influencing the overall hemodynamic stability in PH patients is pulmonary circulation. The method of anaesthesia, the depth of anaesthesia, the mechanical ventilation settings, hypoxemia, hypercapnia, and medications that dilate or constrict pulmonary capillaries are among the factors that alter Pulmonary Artery Pressure (PAP).[4].

Due to an abrupt rise in PVR and delivery-related acute volume overload, the risk of acute RV failure and death is highest in the immediate postpartum period. A retrospective investigation comprising four tertiary North American facilities found that the total mortality rate for pregnant PH patients was 16%, and postpartum death was the cause of death in every case. Therefore, it is essential to keep a constant eye on hemodynamic and, if necessary, to promptly administer treatment in an ICU.[5].

Conclusion

The risk of death from CVDs during pregnancy is highest in PH. The end of danger does not come with delivery, as Anesthesiologists should be aware of. In reality, the majority of PH pregnant women find that delivery itself does not completely resolve their cardiovascular issues. Throughout the peripartum period, the emphasis should be on maintaining hemodynamic stability near to preoperative levels and preventing systemic hypotension, hypoxemia, and acidosis instead of over adjusting.

References

1. Zhu JM, Ma WG, Peterss S, et al.Postoperative epidural morphine is safe on surgical wards. Anesthesiology. 1991; 75(3):452-6.

Indexed at, Google Scholar, Cross Ref

2. Langesaeter E, Rosseland LA, Stubhaug A.Haemodynamic effects of repeated doses of oxytocin during Caesarean delivery in healthy parturients.Br J Anaesth. 2009; 103(2):260-2.

Indexed at, Google Scholar, Cross Ref

3. Thomas JS, Koh SH, Cooper GM.Haemodynamic effects of oxytocin given as iv bolus or infusion on women undergoing Caesarean section.Br J Anaesth. 2007; 98(1):116-9.

Indexed at, Google Scholar,Cross Ref

4. Olsson KM, Halank M, Egenlauf B, et al.Decompensated right heart failure, intensive care and perioperative management in patients with pulmonary hypertension: Updated recommendations from the Cologne Consensus Conference 2018.Int J Cardiol. 2018; 272:46-52.

Indexed at, Google Scholar,Cross Ref

5. Zhang J, Lu J, Zhou X, et al.Perioperative management of pregnant women with idiopathic pulmonary arterial hypertension: an observational case series study from China. J Cardiothorac Vasc Anesth. 2018; 32(6):2547-59.

Indexed at, Google Scholar, Cross Ref